Nangibotide in patients with septic shock: a Phase 2a randomized controlled clinical trial
Bruno François, Xavier Wittebole, Ricard Ferrer, Jean‐Paul Mira, Thierry Dugernier, Sébastien Gibot, Marc Derive, Aurélie Olivier, Valérie Cuvier, Stephan Witte, Peter Pickkers, François Vandenhende, Jean–Jacques Garaud, Miguel Sánchez, Margarita Salcedo‐Magguilli, Pierre‐François Laterre
Topics & Concepts
MedicinePharmacodynamicsSeptic shockPlaceboAdverse effectPharmacokineticsRandomized controlled trialSOFA scorePopulationInternal medicineSepsisAnesthesiaClinical endpointClinical trialAlternative medicineEnvironmental healthPathologyInflammation biomarkers and pathwaysWhipple's Disease and InterleukinsMangiferin and Mango Extracts